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lecystitis is classiﬁ  ed into three grades, mild (grade I), moder-
ate (grade II), and severe (grade III). Grade I (mild acute 
cholecystitis) is deﬁ  ned as acute cholecystitis in a patient with 
no organ dysfunction and limited disease in the gallbladder, 
making cholecystectomy a low-risk procedure. Grade II (mod-
erate acute cholecystitis) is associated with no organ dysfunc-
tion but there is extensive disease in the gallbladder, resulting 
in difﬁ  culty in safely performing a cholecystectomy. Grade II 
disease is usually characterized by an elevated white blood cell 
count; a palpable, tender mass in the right upper abdominal 
quadrant; disease duration of more than 72  h; and imaging 
studies indicating signiﬁ  cant inﬂ  ammatory changes in the gall-
bladder. Grade III (severe acute cholecystitis) is deﬁ  ned as 
acute cholecystitis with organ dysfunction.
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Introduction
Early diagnosis of acute cholecystitis allows prompt 
treatment and reduces both mortality and morbidity. 
Abstract
The aim of this article is to propose new criteria for the diag-
nosis and severity assessment of acute cholecystitis, based on 
a systematic review of the literature and a consensus of ex-
perts. A working group reviewed articles with regard to the 
diagnosis and treatment of acute cholecystitis and extracted 
the best current available evidence. In addition to the evi-
dence and face-to-face discussions, domestic consensus meet-
ings were held by the experts in order to assess the results. A 
provisional outcome statement regarding the diagnostic crite-
ria and criteria for severity assessment was discussed and ﬁ  nal-
ized during an International Consensus Meeting held in Tokyo 
2006. Patients exhibiting one of the local signs of inﬂ  amma-
tion, such as Murphy’s sign, or a mass, pain or tenderness in 
the right upper quadrant, as well as one of the systemic signs 
of inﬂ  ammation, such as fever, elevated white blood cell 
count, and elevated C-reactive protein level, are diagnosed 
as having acute cholecystitis. Patients in whom suspected clini-
cal ﬁ  ndings are conﬁ  rmed by diagnostic imaging are also 
diagnosed with acute cholecystitis. The severity of acute cho-
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The accurate diagnosis of typical as well as atypical 
cases of acute cholecystitis requires speciﬁ  c diagnostic 
criteria. Acute cholecystitis has a better prognosis than 
acute cholangitis, but may require immediate manage-
ment, especially in patients with torsion of the gallblad-
der and emphysematous, gangrenous, or suppurative 
cholecystitis. The lack of standard criteria for diagnosis 
and severity assessment is reﬂ  ected by the wide range 
of reported mortality rates in the literature, and this 
lack makes it impossible to provide standardized opti-
mal treatment guidelines for patients. In these Guide-
lines we propose speciﬁ  c criteria for the diagnosis and 
severity assessment of acute cholecystitis, based on 
the best available evidence and the experts’ consensus 
achieved at the International Consensus Meeting for 
the Management of Acute Cholecystitis and Cholangi-
tis, held on April 1–2, 2006, in Tokyo.
Diagnostic criteria for acute cholecystitis
Diagnosis is the starting point of the management of 
acute cholecystitis, and prompt and timely diagnosis 
should lead to early treatment and lower mortality and 
morbidity. Speciﬁ  c diagnostic criteria are necessary to 
accurately diagnose typical, as well as atypical cases. 
The Guidelines propose diagnostic criteria for acute 
cholecystitis (Table 1). C-reactive protein (CRP) is not 
commonly measured in many countries. However, be-
cause acute cholecystitis is usually associatied with an 
elevation of CRP level by 3  mg/dl or more, CRP was 
included. Diagnosis of acute cholecystitis by elevation 
of CRP level (3  mg/dl or more), with ultrasonographic 
ﬁ  ndings suggesting acute cholecystitis, has a sensitivity 
of 97%, speciﬁ  city of 76%, and positive predictive value 
of 95% (level 1b).1  After the discussion during the 
Tokyo International Consensus Meeting, almost unani-
mous agreement was achieved on the criteria (Table 2). 
However, 19% of the panelists from abroad expressed 
the necessity for minor modiﬁ  cations, because, in the 
provisional version, the diagnostic criteria did not in-
clude technetium hepatobiliery iminodiacetic acid (Tc-
HIDA) scan as an item.
Imaging ﬁ  ndings of acute cholecystitis
Ultrasonography ﬁ  ndings (level 4)2–5
Sonographic Murphy sign (tenderness elicited by press-
ing the gallbladder with the ultrasound probe)
Thickened gallbladder wall (>4 mm; if the patient does 
not have chronic liver disease and/or ascites or right 
heart failure)
Enlarged gallbladder (long axis diameter >8 cm,  short 
axis diameter >4 cm)
Incarcerated gallstone, debris echo, pericholecystic ﬂ  uid 
collection
Sonolucent layer in the gallbladder wall, striated intra-
mural lucencies, and Doppler signals.
Magnetic resonance imaging (MRI) ﬁ  ndings 
(level 1b-4)6–9
Pericholecystic high signal
Enlarged gallbladder
Thickened gallbladder wall.
Computed tomography (CT) ﬁ  ndings (level 3b)10
Thickened gallbladder wall
Pericholecystic ﬂ  uid collection
Enlarged gallbladder
Linear high-density areas in the pericholecystic fat 
tissue.
Table 1.  Diagnostic criteria for acute cholecystitis
A.    Local signs of inﬂ  ammation etc.: 
(1) Murphy’s sign,  (2) RUQ  mass/pain/tenderness
B.    Systemic signs of inﬂ  ammation etc.: 
(1)  Fever, (2)  elevated CRP, (3) elevated WBC count
C.   Imaging  ﬁ  ndings: imaging ﬁ  ndings characteristic of acute 
cholecystitis
Deﬁ  nite diagnosis
(1)  One item in A and one item in B are positive
(2)   C  conﬁ  rms the diagnosis when acute cholecystitis is 
suspected clinically
Note: acute hepatitis, other acute abdominal diseases, and chronic 
cholecystitis should be excluded
Table 2.  Answer pad responses on the diagnostic criteria for acute cholecystitis
    Agree, but needs
    minor
  Agree modiﬁ  cations Disagree
Total (n = 110)    92%   8%  0%
Panelists from abroad (n = 21)   81%  19%  0%
Japanese panelists (n = 20) 100%    0%  0%
Audience (n = 69)   93%    7%  0%80  M. Hirota et al.: Diagnosis and severity assessment of acute cholecystitis
Tc-HIDA scans (level 4)11,12
Non-visualized gallbladder with normal uptake and 
excretion of radioactivity
Rim sign (augmentation of radioactivity around the 
gallbladder fossa).
Severity assessment criteria of acute cholecystitis
Concept of severity grading of acute cholecystitis
Patients with acute cholecystitis may present with a 
spectrum of disease stages ranging from a mild, 
self-limited illness to a fulminant, potentially life-
threatening illness. In these Guidelines we classify the 
severity of acute cholecystitis into the following three 
categories: “mild (grade I)”, “moderate (grade II)”, and 
“severe (grade III)”. A category for the most severe 
grade of acute cholecystitis is needed because this grade 
requires intensive care and urgent treatment (operation 
and/or drainage) to save the patient’s life. However, the 
vast majority of patients present with less severe forms 
of the disease. In these patients, the major practical 
question regarding management is whether it is advis-
able to perform cholecystectomy at the time of presen-
tation in the acute phase or whether other strategies of 
management should be chosen during the acute phase, 
followed by an interval cholecystectomy. Therefore, to 
guide the clinician, the severity grading includes a 
“moderate” group based on criteria predicting when 
conditions might be unfavorable for cholecystectomy in 
the acute phase (level 2b-4).13–18 Patients who fall nei-
ther into the severe nor the moderate group form the 
majority of patients with this disease; their disease is 
suitable for management by cholecystectomy in the 
acute phase, if comorbidities are not a factor. Deﬁ  ni-
tions of the three grades are given below.
Mild (grade I) acute cholecystitis
Mild acute cholecystitis occurs in a patient in whom 
there are no ﬁ  ndings of organ dysfunction, and there is 
mild disease in the gallbladder, allowing for cholecys-
tectomy to be performed as a safe and low-risk proce-
dure. These patients do not have a severity index that 
meets the criteria for “moderate (grade II)” or “severe 
(grade III)” acute cholecystitis.
Moderate (grade II) acute cholecystitis
In moderate acute cholecystitis, the degree of acute 
inﬂ  ammation is likely to be associated with increased 
operative difﬁ  culty to perform a cholecystectomy (level 
2b-4).13–18
Severe (grade III) acute cholecystitis
Severe acute cholecystitis is associated with organ 
dysfunction.
Criteria for the severity assessment of acute cholecystitis
Acute cholecystitis has a better outcome/prognosis than 
acute cholangitis but requires prompt treatment if gan-
grenous cholecystitis, emphysematous cholecystitis, or 
torsion of the gallbladder are present. The progression 
of acute cholecystitis from the mild/moderate to the se-
vere form means the development of the multiple organ 
dysfunction syndrome (MODS). Organ dysfunction 
scores, such as Marshall’s multiple organ dysfunction 
(MOD) score, and the sequential organ failure assess-
ment (SOFA) score, are sometimes used to evaluate 
organ dysfunction in critically ill patients. The Guide-
lines classify the severity of acute cholecystitis into three 
grades (Tables 3–5): “severe (grade III)”: acute chole-
cystitis associated with organ dysfunction, “moderate 
(grade II)”: acute cholecystitis associated with difﬁ  culty 
to perform cholecystectomy due to local inﬂ  ammation, 
and “mild (grade I)”: acute cholecystitis which does not 
meet the criteria of “severe” or “moderate” acute cho-
lecystitis (these patients have acute cholecystitis but no 
Table 3.  Criteria for mild (grade I) acute cholecystitis
“Mild (grade I)” acute cholecystitis does not meet the 
criteria of “severe (grade III)” or “moderate (grade II)” 
acute cholecystitis. Grade I can also be deﬁ  ned as acute 
cholecystitis in a healthy patient with no organ dysfunction 
and only mild inﬂ  ammatory changes in the gallbladder, 
making cholecystectomy a safe and low-risk operative 
procedure.
Table 4.  Criteria for moderate (grade II) acute cholecystitis
“Moderate” acute cholecystitis is accompanied by any one 
of the following conditions:
1.  Elevated WBC count (>18 000/mm3)
2.    Palpable tender mass in the right upper abdominal 
quadrant
3. Duration of  complaints  >72 ha
4.    Marked local inﬂ  ammation (biliary peritonitis, 
pericholecystic abscess, hepatic abscess, gangrenous 
cholecystitis, emphysematous cholecystitis)
a Laparoscopic surgery in acute cholecystitis should be performed 
within 96 h after the onset (level 2b-4)13,14,16
Table 5.  Criteria for severe (grade III) acute cholecystitis
“Severe” acute cholecystitis is accompanied by dysfunctions 
in any one of the following organs/systems
1.    Cardiovascular dysfunction (hypotension requiring 
treatment with dopamine 5 µg/kg per min, or any dose 
of dobutamine)
2.    Neurological dysfunction (decreased level of 
consciousness)
3. Respiratory dysfunction  (PaO2/FiO2 ratio <300)
4.  Renal dysfunction (oliguria, creatinine >2.0 mg/dl)
5. Hepatic dysfunction  (PT-INR  >1.5)
6.  Hematological dysfunction (platelet count <100 000/mm3)M. Hirota et al.: Diagnosis and severity assessment of acute cholecystitis  81
organ dysfunction, and there are mild inﬂ  ammatory 
changes in the gallbladder, so that a cholecystectomy 
can be performed with a low operative risk). Almost 
unanimous agreement on the criteria was achieved 
(Tables 6 and 7). When acute cholecystitis is accompa-
nied by acute cholangitis, the criteria for the severity 
assessment of acute cholangitis should also be taken 
into account. Being “elderly” per se is not a criterion 
for severity itself, but indicates a propensity to progress 
to the severe form, and thus is not included in the cri-
teria for severity assessment.
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Discussion at the Tokyo International 
Consensus Meeting
Diagnostic criteria for acute cholecystitis
The clinical diagnosis of acute cholecystitis is tradition-
ally based on the patient’s clinical presentation, and it 
is conﬁ  rmed by the imaging ﬁ  ndings. Hence, the initial 
provisional diagnostic criteria for acute cholecystitis 
comprised: (1) clinical signs and symptoms, (2) labora-
tory data, and (3) imaging ﬁ  ndings. In the discussion on 
criteria for “clinical signs and symptoms”, 92% of the 
Japanese panelists agreed, whereas only 65% of the 
panelists from abroad agreed and 4% disagreed. In 
regard to the criteria for “laboratory data”, 20% of the 
Japanese panelists and 39% of the panelists from abroad 
voted “agree, but needs minor modiﬁ  cations”. After a 
discussion among the panelists, several changes were 
made. In regard to the proposed criteria for “imaging 
ﬁ  ndings”, 66%–71% of the Japanese panelists agreed 
and about 30% of the panelists voted “agree, but needs 
minor modiﬁ  cations”, and 4% of the panelists from 
abroad disagreed, because Tc-HIDA scans were not 
included. Discussion at the International Consensus 
Meeting led to the reorganization of these categories as: 
(1) local signs of inﬂ  ammation, (2) systemic signs of in-
ﬂ  ammation, and (3) imaging ﬁ  ndings. “Suspected diag-
nosis” in the provisional criteria was deleted, and two 
conditions for “deﬁ  nite diagnosis” were established in 
the ﬁ  nal diagnostic criteria. After the discussion, 100% 
of the Japanese panelists and 81% of the panelists from 
abroad agreed on the ﬁ  nal version (refer to Tables 1 and 
2; consensus was reached).
Severity assessment criteria for acute cholecystitis
Concerning criteria for severe (grade III) acute cholecys-
titis, 81% of the Japanese panelists and 95% of the panel-
ists from abroad agreed with the criteria (refer 
to Tables 5 and 6; consensus was reached). The acute 
physiology and chronic health evaluation II (APACHE 
II) score was not included in the assessment criteria, be-
cause it is too complicated to apply in community 
hospitals.
The criteria for moderate (grade II) acute cholecys-
titis can be deﬁ  ned as acute cholecystitis associated with 
local inﬂ  ammatory conditions that make cholecystecto-
my difﬁ  cult (Steven Strasberg, USA; Dirk J. Gouma, 
the Netherlands; Henry Pitt, USA; Sheung-Tat Fan and 
Joseph W.Y. Lau, Hong Kong; Seraﬁ  n C. Hilvano, Phil-
ippines). On the basis of these aspects, the ﬁ  nal criteria 
for moderate (grade II) acute cholecystitis were deﬁ  ned 
and were agreed on by 91% of the Japanese panelists 
and 77% of those from abroad (refer to Tables 4 and 7; 
consensus was reached).
The criteria for mild (grade I) acute cholecystitis were 
agreed on by approximately 90% of both the Japanese 
panelists and the panelists from abroad (consensus was 
reached).